Language

English

Publication Date

7-1-2022

Journal

Ophthalmology Retina

DOI

10.1016/j.oret.2022.02.001

PMID

35144021

PMCID

PMC8820022

PubMedCentral® Posted Date

2-7-2022

PubMedCentral® Full Text Version

Post-print

Abstract

In this retrospective, multicenter study of 261 eyes (259 patients), patients who underwent rhegmatogenous retinal detachment repair during the coronavirus disease 2019 (COVID-19) post-lockdown period experienced an additional 22-day delay, leading to significantly more epiretinal membrane and proliferative vitreoretinopathy and lower single-surgery anatomic success rates. During lockdown, perfluoropropane gas was used more commonly, and pneumatic retinopexy was used more commonly in COVID-19-positive patients.

Keywords

COVID-19, Communicable Disease Control, Humans, Retinal Detachment, Retrospective Studies, Treatment Outcome, Visual Acuity

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.